Short-term risks and benefits of hydroxyurea (hydroxycarbamide)-induced transfusion independence in patients with beta-thalassaemia syndromes.

ABSTRACT: Clinical outcomes of hydroxyurea (hydroxycarbamide)-induced transfusion independence in patients with β-thalassaemia syndromes.

SUBMITTER: Sevanthini BR 

PROVIDER: S-EPMC12624206 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature